We use cookies on our website to improve the website and your experience.
Read moreCell & Gene Manufacturing and Commercialization USA
19 Sep 2023Albumedix, now a part of Sartorius, will showcase the Recombumin® recombinant human albumin portfolio at the Cell and Gene Therapy Manufacturing and Commercialization Conference September 19-21, 2023
The cell and gene therapy event for ground-breaking manufacturing, commercialization, and supply chain strategies where World renowned leaders share the latest bioprocessing science and technologies to improve manufacturing scalability, cost, and quality to increase access to patients in rare diseases and beyond. Speak to our team about how Recombumin could improve your pharmaceutical at the event, or get in touch today.